We use cookies for a better user experience. Read our Privacy Policy

I Agree

Breast Tissue Markers Market

Breast Tissue Markers Market (Product: Coil, Ribbon, Bowtie, Butterfly, U Shape, and Others; and Material: Non-biodegradable and Partially Biodegradable) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Breast Tissue Markers Market Outlook 2031

  • The global breast tissue markers market was valued at US$ 2.5 Bn in 2021
  • The global market is projected to advance at a CAGR of 8.3% from 2022 to 2031
  • The global breast tissue markers market is anticipated to reach more than US$ 5.8 Bn by the end of 2031

Analysts’ Viewpoint on Breast Tissue Markers Market Scenario

Rise in number of breast cancer cases has compelled governments across the world to spread awareness about the importance of early detection of breast cancer. This is expected to drive global breast tissue markers market size in the next few years. Breast tissue markers give the surgeon an advantage in identifying and marking the biopsy area with a physical tag, allowing him to diagnose and operate more effectively. A standard stainless steel marker is used in the traditional method. More advanced breast tissue markers, such as partially bio-absorbable and mineral-based markers, are used to ensure complete patient satisfaction. Key players in the market are launching new tissue marker breast biopsy products to enhance their market share. Increase in adoption of tissue markers is likely to augment the global breast tissue markers market growth in the near future.

Breast Tissue Markers Market

Breast Tissue Markers Market Introduction

Breast tissue markers are commonly used in mammography diagnostic imaging. Typically, these are implanted just after a percutaneous biopsy under ultrasonic or stereotactic guidelines. On follow-up imaging, these can be extremely helpful in identifying relatively harmless regions or shrinking/treated malignant lesions. Breast tissue markers are now available in various shapes, compositions, and partially bio-absorbable components. Ribbon, coil, and wing markers with easily distinguishable appearances on mammograms are among the makers currently in use. New ultrasound-detectable markers are also available in the market. Breast tissue markers can be used to guide subsequent radiotherapy treatments with clips inserted prior to surgery (localization wire targets).

Request a sample to get extensive insights into the Breast Tissue Markers Market

Increase in Demand for Biodegradable Breast Tissue Markers Driving Global Market

In a biopsy procedure, a metal clip with a 3 mm diameter is commonly used as a radio marker so that the lesion can be clearly identified on subsequent imaging inspection. A metal clip marker remains in the breast indefinitely. This is a significant disadvantage. Therefore, most women refuse to have a biopsy. This is exacerbated when a patient has had numerous breast biopsies and much more than a metal clip marker is implanted to differentiate abnormal lesions on a mammography. Furthermore, metal clips migrate away from the biopsy insertion site after deployment. Another disadvantage of metal markers is that they cause issues during MRI because of changes in the local magnetic field caused by the implants' ferromagnetic, paramagnetic, and diamagnetic properties. This could reduce MRI's sensitivity for breast cancer detection and treatment monitoring. Therefore, biodegradable breast tissue markers are being developed as implants in the breast biopsy market. These biodegradable breast biopsy markers have the potential to serve as visual markers for breast tumor growth regions for the required follow-up period, such as six months, before being completely eliminated from the body.

Breast Cancer Awareness and Screening Programs Fueling Global Market

Regional government authorities are launching breast cancer awareness and screening programs to reduce the mortality rates associated with breast cancer. Breast cancer therapeutics are becoming more effective in the treatment of the disease, with more than 90% survival probabilities, especially when the disease is detected early. According to the World Health Organization, around 2.3 million new cases of breast cancer and 685,000 deaths were recorded globally in 2020. Breast cancer has been diagnosed in 7.8 million women in the previous five years ending 2020, making it the world's most common cancer.

Initiation of breast cancer awareness campaigns by public organizations is expected to encourage breast cancer learning and breast cancer therapeutic applications. The National Breast Cancer Foundation launched ‘October as Breast Cancer Awareness Month,’ a campaign to increase awareness about the dangers of breast cancer. Such efforts are expected to encourage recently diagnosed breast cancer patients, thereby driving the global market.

Request a custom report on Breast Tissue Markers Market

Rise in Number of Breast Biopsy Procedures Offering Growth Opportunities to Market Players

Breast biopsies are typically used to diagnose breast cancer, but these can also be used to screen for other diseases discovered during a physical examination. Breast biopsies are commonly performed using fine needle aspiration biopsy, which is one of the least invasive procedures available. It also does not leave any scarring. A needle is inserted through the dermal tissue of the breast to remove tissue. Another technique, known as stereotactic needle biopsy in combination with a mammogram, guides this same biopsy with ultrasound radiation. The ultrasound tracker directs the needle to the chosen place in the breast during treatment. Stereotactic mammography is a method that employs images taken from different vantage points to identify the site of a malignant tumor in addition to the placement of the needle used to acquire a breast biopsy sample. Thus, breast marker is a small titanium or stainless steel marker the size of a sesame seed. Breast biopsy markers are used to pinpoint the location of the breast tissue removed during a biopsy procedure.

Application in Identifying and Marking Biopsy Area Bolstering Coil Segment

In terms of product, the global breast tissue markers market has been classified into coil, ribbon, bowtie, butterfly, bowtie, U shape, and others. Coil breast tissue markers are commonly used in partially biodegradable breast tissue markers. These breast tissue markers help a surgeon diagnose and operate more effectively by identifying and marking the biopsy area with a physical tag. Furthermore, mergers and acquisitions are projected to drive the coil segment in the near future. For instance, Mammotome announced the launch of a new product line of flexible HydroMARK Breast Biopsy Site Marker applicators designed to improve the clinician's user experience. The new applicator line expands compatibility with leading vacuum-assisted breast biopsy systems, bringing the HydroMARK markers to more customers in more clinical settings.

Increase in Usage of Non-biodegradable Markers Across Globe

Based on material, the global breast tissue markers market has been bifurcated into partially biodegradable and non-biodegradable. Non-biodegradable clips are made up of titanium, with no absorbable PVA polymer pellet or other materials. Titanium is widely used in breast tissue markers. The breast tissue markers market is focusing on end-user education and training. Several companies operating in the global market are providing their products at reasonable prices.

Availability of High-quality Care Bolstering Hospitals Segment

In terms of end-user, the global breast tissue markers market has been divided into hospitals, ambulatory surgical centers, diagnostic centers, and specialty clinics. Increasing number of patients are seeking hospitals that provide patient-centered care. In other words, these hospitals establish a reputation of offering patients high-quality care, giving them a competitive edge over institutions that continue to rely on outdated practices. Overall decrease in hospital care expenses is also projected to drive the hospitals segment during the forecast period.

Regional Outlook of Global Breast Tissue Markers Market

North America accounted for major share of around 40.0% of the global breast tissue markers market in 2021. According to the breast tissue markers market forecast, the region is anticipated to dominate the global breast tissue markers market in the next few years owing to the presence of major players, established diagnostic & screening infrastructure, technological advancements, high patient awareness, and favorable reimbursement policies. The prevalence of breast cancer is rising in North America. This has increased the usage of advanced diagnostic techniques in the region. The market in North America is expected to be driven by expanding healthcare infrastructure and favorable reimbursement policies in the region. Increase in disposable income, rapid urbanization, improved health care infrastructure, and distribution and partnership strategies adopted by key players are also propelling the market in the region.

The breast tissue markers market in Asia Pacific is expected to grow at the fastest CAGR during the forecast period due to the surge in incidence of breast cancer and adoption of advanced diagnostic techniques in the region. Furthermore, rise in healthcare infrastructure and improving reimbursement guidelines are likely to augment the market in Asia Pacific.

Analysis of Key Players in Global Breast Tissue Markers Market

The global breast tissue markers market is consolidated, with the presence of a small number of leading players. Most of the companies are investing significantly in R&D activities, primarily to introduce advanced breast tissue markers such as BioZorb tissue markers. Key players are engaging in strategic alliances to increase revenue and market share. Furthermore, diversification of product portfolios and mergers & acquisitions are the major strategies adopted by the players. Mammotome, BD, Hologic, Inc., Carbon Medical Technologies, Inc., Scion Medical Technologies, LLC, Mermaid Medical, and SOMATEX Medical Technologies GmbH are prominent players operating in the global breast tissue markers market.

Key Developments in Global Breast Tissue Markers Market

  • In December 2021, Roche released its most recent digital pathology algorithms based on artificial intelligence (AI) to help pathologists evaluate Ki-67, ER, and PR breast cancer markers. The decision to choose a patient's therapy could be affected by the laborious manual methods for quantification of breast cancer markers, which have reported significant interobserver variability.
  • In 2021, Hologic, Inc., an innovative medical technology company primarily focused on improving women's health, announced the completion of the acquisition of SOMATEX Medical Technologies GmbH for around US$ 64 Mn. E-Med Solutions GmbH, a group of investors led by Westlake Partners, a Germany-based private equity firm, previously owned the company.

Each of these players has been profiled in the breast tissue markers market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Breast Tissue Markers Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 2.5 Bn

Market Forecast Value in 2031

More than US$ 5.8 Bn

Growth Rate

(CAGR)

8.3%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and key trend analysis.

Competition Landscape

  • Company profiles section includes overview, product portfolio, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product
    • Coil
    • Ribbon
    • Bowtie
    • Butterfly
    • U Shape
    • Others
  • Material
    • Non-biodegradable
    • Partially Biodegradable
  • End-user
    • Hospitals
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Specialty Clinics

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • China
  • Japan
  • South Korea
  • Singapore
  • Brazil
  • Argentina
  • Chile

Companies Profiled

  • Mammotome
  • BD
  • Hologic, Inc.
  • Carbon Medical Technologies, Inc.
  • Scion Medical Technologies, LLC
  • Mermaid Medical
  • SOMATEX Medical Technologies GmbH

Customization Scope

Available upon request

Pricing

Available upon request

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

How big was the global breast tissue markers market in 2021?

The global breast tissue markers market was valued at US$ 2.5 Bn in 2021

How big will be the global breast tissue markers market in 2031?

The global breast tissue markers market is projected to reach more than US$ 5.8 Bn by 2031

What will be the CAGR of the global breast tissue markers market during the forecast period (2022–2031)?

The global breast tissue markers market is anticipated to grow at a CAGR of 8.3% from 2022 to 2031

Which are the prominent trends that affect market growth?

Rise in number of breast cancer cases is driving the global breast tissue markers market

What is the market share of the leading segment of the global breast tissue markers market?

The non-biodegradable segment held more than 57% share of the global breast tissue markers market in 2021

Who are the prominent players in the global breast tissue markers market?

Mammotome, BD, Hologic, Inc., Carbon Medical Technologies, Inc., Scion Medical Technologies, LLC, Mermaid Medical, and SOMATEX Medical Technologies GmbH

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Breast Tissue Markers Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Breast Tissue Markers Market Analysis and Forecast, 2017 - 2031

        4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

    5.1. Key product/brand Analysis

    5.2. Pipeline Analysis

    5.3. Side Effects of Breast Tissue Markers

    5.4. Patents

    5.5. Key Mergers & Acquisitions

    5.6. Pricing Analysis

    5.7. Application of Clip Markers (outside mammography)

    5.8. Breast Tissue Markers used per case

    5.9. Disease Prevalence & Incidence Rate globally with key countries

    5.10. COVID 19 Impact Analysis

6. Global Breast Tissue Markers Market Analysis and Forecast, By Product

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product, 2017–2031

        6.3.1. Coil

        6.3.2. Ribbon

        6.3.3. Bowtie

        6.3.4. Butterfly

        6.3.5. Wing

        6.3.6. U Shape

        6.3.7. Others

    6.4. Market Attractiveness Analysis, by Product

7. Global Breast Tissue Markers Market Analysis and Forecast, By Material

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market ValueForecast, by Material, 2017 - 2031

        7.3.1. Non-biodegradable

        7.3.2. Partially Biodegradable

    7.4. Market Attractiveness Analysis, by Material

8. Global Breast Tissue Markers Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by End-user, 2017–2031

        8.3.1. Hospitals

        8.3.2. Ambulatory Surgical Centers

        8.3.3. Diagnostic Centers

        8.3.4. Specialty Clinics

    8.4. Market Attractiveness Analysis, by End-user

9. Global Breast Tissue Markers Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

10. North America Breast Tissue Markers Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product, 2017 - 2031

        10.2.1. Coil

        10.2.2. Ribbon

        10.2.3. Bowtie

        10.2.4. Butterfly

        10.2.5. Wing

        10.2.6. U shape

        10.2.7. Others

    10.3. Market Value Forecast, by Material, 2017 - 2031

        10.3.1. Non-biodegradable

        10.3.2. Partially Biodegradable

    10.4. Market Value Forecast, by End-user, 2017 - 2031

        10.4.1. Hospitals

        10.4.2. Ambulatory Surgical Centers

        10.4.3. Diagnostic Centers

        10.4.4. Specialty Clinics

    10.5. Market Value Forecast, by Country, 2017 - 2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Product

        10.6.2. By Material

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Breast Tissue Markers Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product, 2017 - 2031

        11.2.1. Coil

        11.2.2. Ribbon

        11.2.3. Bowtie

        11.2.4. Butterfly

        11.2.5. Wing

        11.2.6. U shape

        11.2.7. Others

    11.3. Market Value Forecast, by Material, 2017 - 2031

        11.3.1. Non-biodegradable

        11.3.2. Partially Biodegradable

    11.4. Market Value Forecast, by End-user, 2017 - 2031

        11.4.1. Hospitals

        11.4.2. Ambulatory Surgical Centers

        11.4.3. Diagnostic Centers

        11.4.4. Specialty Clinics

    11.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Product

        11.6.2. By Material

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Latin America Breast Tissue Markers Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2017 - 2031

        12.2.1. Coil

        12.2.2. Ribbon

        12.2.3. Bowtie

        12.2.4. Butterfly

        12.2.5. Wing

        12.2.6. U shape

        12.2.7. Others

    12.3. Market Value Forecast, by Material, 2017 - 2031

        12.3.1. Non-biodegradable

        12.3.2. Partially Biodegradable

    12.4. Market Value Forecast, by End-user, 2017 - 2031

        12.4.1. Hospitals

        12.4.2. Ambulatory Surgical Centers

        12.4.3. Diagnostic Centers

        12.4.4. Specialty Clinics

    12.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031

        12.5.1. Brazil

        12.5.2. Mexico

        12.5.3. Rest of Latin America

    12.6. Market Attractiveness Analysis

        12.6.1. By Product

        12.6.2. By Application

        12.6.3. By Degree of Cooling

        12.6.4. By Country/Sub-region

13. Middle East & Africa Breast Tissue Markers Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product, 2017 - 2031

        13.2.1. Coil

        13.2.2. Ribbon

        13.2.3. Bowtie

        13.2.4. Butterfly

        13.2.5. Wing

        13.2.6. U shape

        13.2.7. Others

    13.3. Market Value Forecast, by Material, 2017 - 2031

        13.3.1. Non-biodegradable

        13.3.2. Partially Biodegradable

    13.4. Market Value Forecast, by End-user, 2017 - 2031

        13.4.1. Hospitals

        13.4.2. Ambulatory Surgical Centers

        13.4.3. Diagnostic Centers

        13.4.4. Specialty Clinics

    13.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031

        13.5.1. GCC Countries

        13.5.2. South Africa

        13.5.3. Rest of Middle East & Africa

    13.6. Market Attractiveness Analysis

        13.6.1. By Product

        13.6.2. By Application

        13.6.3. By Degree of Cooling

        13.6.4. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player – Competition Matrix (by tier and size of companies)

    14.2. Market Share Analysis, by Company, 2018

    14.3. Company Profiles

        14.3.1. Mammotome

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Company Financials

            14.3.1.3. Growth Strategies

            14.3.1.4. SWOT Analysis

        14.3.2. BD

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Company Financials

            14.3.2.3. Growth Strategies

            14.3.2.4. SWOT Analysis

        14.3.3. Hologic, Inc.

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Company Financials

            14.3.3.3. Growth Strategies

            14.3.3.4. SWOT Analysis

        14.3.4. Carbon Medical Technologies, Inc.

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Company Financials

            14.3.4.3. Growth Strategies

            14.3.4.4. SWOT Analysis

        14.3.5. Scion Medical Technologies, LLC

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Company Financials

            14.3.5.3. Growth Strategies

            14.3.5.4. SWOT Analysis

        14.3.6. Mermaid Medical

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Company Financials

            14.3.6.3. Growth Strategies

            14.3.6.4. SWOT Analysis

        14.3.7. SOMATEX Medical Technologies GmbH

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Company Financials

            14.3.7.3. Growth Strategies

            14.3.7.4. SWOT Analysis

List of Tables

Table 01: Global Breast Tissue Markers Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global Breast Tissue Markers Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 03: Global Breast Tissue Markers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Breast Tissue Markers Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Breast Tissue Markers Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Breast Tissue Markers Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 07: North America Breast Tissue Markers Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 08: North America Breast Tissue Markers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Breast Tissue Markers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Breast Tissue Markers Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 11: Europe Breast Tissue Markers Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 12: Europe Breast Tissue Markers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Asia Pacific Breast Tissue Markers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Breast Tissue Markers Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 15: Asia Pacific Breast Tissue Markers Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 16: Asia Pacific Breast Tissue Markers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America Breast Tissue Markers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Breast Tissue Markers Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 19: Latin America Breast Tissue Markers Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 20: Latin America Breast Tissue Markers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa Breast Tissue Markers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Breast Tissue Markers Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 23: Middle East & Africa Breast Tissue Markers Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 24: Middle East & Africa Breast Tissue Markers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 1: Global Breast Tissue Markers Market, by Product, 2021 and 2031

Figure 2: Global Breast Tissue Markers Market Attractiveness Analysis, by Product, 2022–2031

Figure 3: Global Breast Tissue Markers Market (US$ Mn), by Coil, 2017–2031

Figure 4: Global Breast Tissue Markers Market (US$ Mn), by Ribbon, 2017–2031

Figure 5: Global Breast Tissue Markers Market (US$ Mn), by Bowtie, 2017–2031

Figure 6: Global Breast Tissue Markers Market (US$ Mn), by Butterfly, 2017–2031

Figure 7: Global Breast Tissue Markers Market (US$ Mn), by Wing, 2017–2031

Figure 8: Global Breast Tissue Markers Market (US$ Mn), by U shape, 2017–2031

Figure 9: Global Breast Tissue Markers Market (US$ Mn), by Others, 2017–2031

Figure 10: Global Breast Tissue Markers Market, by Material, 2021 and 2031

Figure 11: Global Breast Tissue Markers Market Attractiveness Analysis, by Product, 2022–2031

Figure 12: Global Breast Tissue Markers Market (US$ Mn), by Partially Biodegradable, 2017–2031

Figure 13: Global Breast Tissue Markers Market (US$ Mn), by Non-biodegradable, 2017–2031

Figure 14: Global Breast Tissue Markers Market, by End-user, 2021 and 2031

Figure 15: Global Breast Tissue Markers Market Attractiveness Analysis, by End-user, 2022–2031

Figure 16: Global Breast Tissue Markers Market (US$ Mn), by Hospitals, 2017–2031

Figure 17: Global Breast Tissue Markers Market (US$ Mn), by Ambulatory Surgical Centers, 2017–2031

Figure 18: Global Breast Tissue Markers Market (US$ Mn), by Diagnostic Centers, 2017–2031

Figure 19: Global Breast Tissue Markers Market (US$ Mn), by Specialty Clinics, 2017–2031

Figure 20: Global Breast Tissue Markers Market Value Share Analysis, by Region, 2021 and 2031

Figure 21: Global Breast Tissue Markers Market Attractiveness Analysis, by Region, 2022–2031

Figure 22: North America Breast Tissue Markers Market Value (US$ Mn) Forecast, 2017–2031

Figure 23: North America Breast Tissue Markers Market Value Share Analysis, by Country, 2021 and 2031

Figure 24: North America Breast Tissue Markers Market Attractiveness Analysis, by Country, 2022–2031

Figure 25: North America Breast Tissue Markers Market, by Product, 2021 and 2031

Figure 26: North America Breast Tissue Markers Market Attractiveness Analysis, by Product, 2022–2031

Figure 27: North America Breast Tissue Markers Market, by Material, 2021 and 2031

Figure 28: North America Breast Tissue Markers Market Attractiveness Analysis, by Material, 2022–2031

Figure 29: North America Breast Tissue Markers Market, by End-user, 2021 and 2031

Figure 30: North America Breast Tissue Markers Market Attractiveness Analysis, by End-user, 2022–2031

Figure 31: Europe Breast Tissue Markers Market Value (US$ Mn) Forecast, 2017–2031

Figure 32: Europe Breast Tissue Markers Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 33: Europe Breast Tissue Markers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 34: Europe Breast Tissue Markers Market, by Product, 2021 and 2031

Figure 35: Europe Breast Tissue Markers Market Attractiveness Analysis, by Product, 2022–2031

Figure 36: Europe Breast Tissue Markers Market, by Material, 2021 and 2031

Figure 37: Europe Breast Tissue Markers Market Attractiveness Analysis, by Material, 2022–2031

Figure 38: Europe Breast Tissue Markers Market, by End-user, 2021 and 2031

Figure 39: Europe Breast Tissue Markers Market Attractiveness Analysis, by End-user, 2022–2031

Figure 40: Asia Pacific Breast Tissue Markers Market Value (US$ Mn) Forecast, 2017–2031

Figure 41: Asia Pacific Breast Tissue Markers Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 42: Asia Pacific Breast Tissue Markers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 43: Asia Pacific Breast Tissue Markers Market, by Product, 2021 and 2031

Figure 44: Asia Pacific Breast Tissue Markers Market Attractiveness Analysis, by Product, 2022–2031

Figure 45: Asia Pacific Breast Tissue Markers Market, by Material, 2021 and 2031

Figure 46: Asia Pacific Breast Tissue Markers Market Attractiveness Analysis, by Material, 2022–2031

Figure 47: Asia Pacific Breast Tissue Markers Market, by End-user, 2021 and 2031

Figure 48: Asia Pacific Breast Tissue Markers Market Attractiveness Analysis, by End-user, 2022–2031

Figure 49: Latin America Breast Tissue Markers Market Value (US$ Mn) Forecast, 2017–2031

Figure 50: Latin America Breast Tissue Markers Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 51: Latin America Breast Tissue Markers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 52: Latin America Breast Tissue Markers Market, by Product, 2021 and 2031

Figure 53: Latin America Breast Tissue Markers Market Attractiveness Analysis, by Product, 2022–2031

Figure 54: Latin America Breast Tissue Markers Market, by Material, 2021 and 2031

Figure 55: Latin America Breast Tissue Markers Market Attractiveness Analysis, by Material, 2022–2031

Figure 56: Latin America Breast Tissue Markers Market, by End-user, 2021 and 2031

Figure 57: Latin America Breast Tissue Markers Market Attractiveness Analysis, by End-user, 2022–2031

Figure 58: Middle East & Africa Breast Tissue Markers Market Value (US$ Mn) Forecast, 2017–2031

Figure 59: Middle East & Africa Breast Tissue Markers Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 60: Middle East & Africa Breast Tissue Markers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 61: Middle East & Africa Breast Tissue Markers Market, by Product, 2021 and 2031

Figure 62: Middle East & Africa Breast Tissue Markers Market Attractiveness Analysis, by Product, 2022–2031

Figure 63: Middle East & Africa Breast Tissue Markers Market, by Material, 2021 and 2031

Figure 64: Middle East & Africa Breast Tissue Markers Market Attractiveness Analysis, by Material, 2022–2031

Figure 65: Middle East & Africa Breast Tissue Markers Market, by End-user, 2021 and 2031

Figure 66: Middle East & Africa Breast Tissue Markers Market Attractiveness Analysis, by End-user, 2022–2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

982

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved